149 related articles for article (PubMed ID: 30867411)
1. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
2. Prader-Willi region non-protein coding RNA 1 suppressed gastric cancer growth as a competing endogenous RNA of
Chen Z; Ju H; Yu S; Zhao T; Jing X; Li P; Jia J; Li N; Tan B; Li Y
Clin Sci (Lond); 2018 May; 132(9):1003-1019. PubMed ID: 29535266
[TBL] [Abstract][Full Text] [Related]
3. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.
Ma L; He H; Jiang K; Jiang P; He H; Feng S; Chen K; Shao J; Deng G
Aging (Albany NY); 2020 Apr; 12(7):6352-6369. PubMed ID: 32283544
[TBL] [Abstract][Full Text] [Related]
4. Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway.
Martinez JD; Mo Q; Xu Y; Qin L; Li Y; Xu J
Int J Biol Sci; 2022; 18(1):229-241. PubMed ID: 34975329
[TBL] [Abstract][Full Text] [Related]
5. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
[TBL] [Abstract][Full Text] [Related]
6. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo.
Chiang KC; Chen HY; Hsu SY; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Sun CC; Lee JM; Yeh CN; Juang HH
Drug Des Devel Ther; 2015; 9():4631-8. PubMed ID: 26316702
[TBL] [Abstract][Full Text] [Related]
7. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN.
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2019 Jun; 44():298-310. PubMed ID: 31201145
[TBL] [Abstract][Full Text] [Related]
8. [Effects of plumbagin on proliferation and apoptosis of human hepatocellular carcinoma cells based on CKB/p53 signaling pathway].
Zhou FL; Yuan B; Ye YX; Deng SY; Ma J; Liu H; Ma YZ; Wei YF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2345-2354. PubMed ID: 38812135
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.
Liang Y; Li Y; Song X; Zhang N; Sang Y; Zhang H; Liu Y; Chen B; Zhao W; Wang L; Guo R; Yu Z; Yang Q
Cancer Biol Ther; 2018 Feb; 19(2):120-131. PubMed ID: 29293402
[TBL] [Abstract][Full Text] [Related]
10. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract][Full Text] [Related]
11. MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway.
Liu J; Zhang J; Zhang Y; Yang B; Liu H; Chen Y
Funct Integr Genomics; 2024 Apr; 24(2):71. PubMed ID: 38568332
[TBL] [Abstract][Full Text] [Related]
12. Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice
El-Aarag B; Shalaan ES; Ahmed AAS; El Sayed IET; Ibrahim WM
Anticancer Agents Med Chem; 2024; 24(6):436-442. PubMed ID: 38305388
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PTEN expression by noncoding RNAs.
Li W; Zhang T; Guo L; Huang L
J Exp Clin Cancer Res; 2018 Sep; 37(1):223. PubMed ID: 30217221
[TBL] [Abstract][Full Text] [Related]
14. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
15. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
[TBL] [Abstract][Full Text] [Related]
16. FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation.
Tomiyasu H; Habara M; Hanaki S; Sato Y; Miki Y; Shimada M
J Biol Chem; 2024 Apr; 300(4):107209. PubMed ID: 38519029
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
18. RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.
Gottlieb A; Althoff K; Grunewald L; Thor T; Odersky A; Schulte M; Deubzer HE; Heukamp L; Eggert A; Schramm A; Schulte JH; Künkele A
Oncotarget; 2017 Apr; 8(17):27882-27891. PubMed ID: 28427187
[TBL] [Abstract][Full Text] [Related]
19. Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.
Liu JC; Voisin V; Wang S; Wang DY; Jones RA; Datti A; Uehling D; Al-awar R; Egan SE; Bader GD; Tsao M; Mak TW; Zacksenhaus E
EMBO Mol Med; 2014 Dec; 6(12):1542-60. PubMed ID: 25330770
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.
De Velasco MA; Kura Y; Yoshikawa K; Nishio K; Davies BR; Uemura H
Oncotarget; 2016 Mar; 7(13):15959-76. PubMed ID: 26910118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
